Latest European Markets News

Page 2 of 22
Credit Clear Limited posted a 28% rise in FY26 revenue to $60 million, boosted by UK acquisitions and organic growth, while defending legal action by the ACCC.
Claire Turing
Claire Turing
27 Aug 2026
Neuren Pharmaceuticals reported an 8% rise in H1 2026 revenues driven by DAYBUE royalties, but profit fell 68% due to ramped-up R&D. The company declared its first ever dividend, signalling confidence amid ongoing clinical and regulatory milestones.
Ada Torres
Ada Torres
26 Aug 2026
The Koala Company posted a $24.6 million profit for FY26 on $332.3 million revenue, surpassing IPO forecasts with strong international growth and margin gains.
Victor Sage
Victor Sage
26 Aug 2026
Camplify Holdings slashed its net loss by 95% in FY26, posting a second-half profit driven by cost cuts and the MyWay Mutual insurance launch, setting a foundation for growth in FY27.
Sophie Babbage
Sophie Babbage
26 Aug 2026
Neuren Pharmaceuticals’ partner Acadia Pharmaceuticals secured European Commission approval for DAYBU (trofinetide) to treat Rett syndrome symptoms in patients aged five and older, marking the first EU-authorised treatment for this condition.
Victor Sage
Victor Sage
25 Aug 2026
Comms Group Limited reported record FY26 revenue and EBITDA growth, driven by organic expansion and TasmaNet acquisition, while progressing the $30m sale of its ICT business to streamline operations and support shareholder returns.
Sophie Babbage
Sophie Babbage
24 Aug 2026
Aurora Labs posted a 36% increase in net loss to $5.1 million for FY2026 despite securing key defence contracts and partnerships. The company is transitioning from R&D to early commercialisation of its micro gas turbine propulsion systems, backed by a $5.5 million capital raise and government grants.
Victor Sage
Victor Sage
21 Aug 2026
Medical Developments International (ASX:MVP) reported a 9% revenue increase to $42.6 million and a 566% jump in net profit to $0.6 million for FY26, driven by robust growth in its Pain Management segment and expanded paediatric approvals in Europe.
Ada Torres
Ada Torres
20 Aug 2026
Skellerup Holdings delivered a tenth consecutive year of EBIT growth with a 14% rise to NZD 89.3 million and expanded its climate initiatives, reporting a 24% jump in net profit to NZD 67.7 million.
Victor Sage
Victor Sage
20 Aug 2026
Atomo Diagnostics has appointed Dr Cheri Walker as interim CEO, replacing founder John Kelly who steps down after 15 years. The leadership change aligns with the company's shift towards commercial growth in the US and Europe.
Ada Torres
Ada Torres
19 Aug 2026
Osmond Resources has reinforced the continuity of high-grade critical minerals at its Orión project in Spain, with drill hole SOR-07A delivering promising assay results. The company is on track to release its maiden Mineral Resource Estimate and Scoping Study by Q3 2026, supported by robust mineral processing testwork and a new Frankfurt listing.
Maxwell Dee
Maxwell Dee
14 Aug 2026
Brazilian Rare Earths (ASX: BRE) has delivered a striking scoping study for its Rocha da Rocha Rare Earths Province in Brazil, anchored by the Monte Alto deposit’s world-class 11.3% TREO grade, projecting robust economics and a low-cost production path.
Maxwell Dee
Maxwell Dee
13 Aug 2026

Browse the archive

Full archive